Condition: Healthy · Non-diabetic Overweight or Obese · Sponsor: BrightGene Bio-Medical Technology Co., Ltd.
A Randomized, Double-Blind, Placebo-Controlled, Single/Multiple-dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BGM0504 Tablets Orally Administered in Healthy and Non-diabetic Overweight or Obese Chinese Subjects.
This description comes directly from the study's public registry record.
Jianchang He · 13700680697 · hejc@yn-cprc.com
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital of Yunnan University of Chinese Medicine | Kunming, Yunnan, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07239973